Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IDEAYA Biosciences, Inc. - Common Stock (NQ:IDYA)

32.75 +0.15 (+0.46%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,403,061
Open 32.51
Bid (Size) 31.50 (300)
Ask (Size) 37.00 (300)
Prev. Close 32.60
Today's Range 32.16 - 33.51
52wk Range 13.45 - 39.28
Shares Outstanding 48,390,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
A Healthcare Hedge Fund Just Added $24.5 Million in Immunovant Stock. Should you? ↗
This clinical-stage biotech develops antibody therapies targeting autoimmune diseases, with a lead candidate in Phase II trials. 
Via The Motley Fool
A Whole Watchlist of “Coiled Springs” (Found With One Simple ChartMill Screen) ↗
Via Chartmill

Performance

YTD
-3.2%
-3.2%
1 Month
-0.5%
-0.5%
3 Month
-7.7%
-7.7%
6 Month
+26.4%
+26.4%
1 Year
+78.1%
+78.1%

More News

Read More
News headline image
IDEAYA Biosciences Inc (NASDAQ:IDYA) Shows Strong Technical Setup for Potential Breakout ↗
Via Chartmill
News headline image
SLB To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
Via Benzinga
News headline image
Buying IDEAYA Might Be The Wrong IDYA Right Now ↗
Via Benzinga
News headline image
Alibaba To Rally Around 35%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Via Benzinga
News headline image
IDEAYA (IDYA) Q2 Net Loss Improves 27% ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
This Royal Caribbean Cruises Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday ↗
Via Benzinga
News headline image
This Trade Desk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗
Via Benzinga
News headline image
This NRG Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗
Via Benzinga
News headline image
Jim Cramer Says This Tobacco Stock Is 'Undervalued' But He's Not Recommending It ↗
Via Benzinga
News headline image
Biocytogen Announces IDEAYA’s Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise
From Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Via Business Wire
News headline image
This Cognex Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗
Via Benzinga
News headline image
Ideaya Biosciences Stock Tumbles Despite Promising Data From Rare Eye Cancer Candidate ↗
Via Benzinga
News headline image
Oracle To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
Via Benzinga
News headline image
IDYA Stock Earnings: IDEAYA Biosciences Misses EPS for Q2 2024 ↗
Via InvestorPlace
News headline image
Week In Review: ImmuneOnco Out-Licenses Two Antibodies In $2 Billion Deal ↗
Via Talk Markets
News headline image
MarketBeat Week in Review – 7/15 - 7/19
Via MarketBeat
Topics Economy
News headline image
Positive News is Driving This Cancer Drug Maker’s Stock Higher
Via MarketBeat
News headline image
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Via Benzinga
News headline image
Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Via Benzinga
News headline image
IDEAYA Biosciences Highlights 'Encouraging' Preliminary Efficacy, Safety Profile For Patients With Hard-To-Treat Cancer ↗
Via Benzinga
News headline image
Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday ↗
Via Benzinga

Frequently Asked Questions

Is IDEAYA Biosciences, Inc. - Common Stock publicly traded?
Yes, IDEAYA Biosciences, Inc. - Common Stock is publicly traded.
What exchange does IDEAYA Biosciences, Inc. - Common Stock trade on?
IDEAYA Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for IDEAYA Biosciences, Inc. - Common Stock?
The ticker symbol for IDEAYA Biosciences, Inc. - Common Stock is IDYA on the Nasdaq Stock Market
What is the current price of IDEAYA Biosciences, Inc. - Common Stock?
The current price of IDEAYA Biosciences, Inc. - Common Stock is 32.75
When was IDEAYA Biosciences, Inc. - Common Stock last traded?
The last trade of IDEAYA Biosciences, Inc. - Common Stock was at 03/20/26 04:00 PM ET
What is the market capitalization of IDEAYA Biosciences, Inc. - Common Stock?
The market capitalization of IDEAYA Biosciences, Inc. - Common Stock is 1.58B
How many shares of IDEAYA Biosciences, Inc. - Common Stock are outstanding?
IDEAYA Biosciences, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.